On Wednesday, September 17th, the Rare Disease Company Coalition (RDCC) held “America Leads: Sustaining U.S. Innovation in Rare Disease.” This virtual briefing examined how the United States became a global leader in rare disease treatment and the policies that will shape its role. Panelists shared perspectives from across the rare disease innovation ecosystem.
For more information and to watch the briefing, click here.